Chc Healthcare Group · TWSE:4164
Chc Healthcare — 2017 2nd Institutional Investor Conference
29 slides from Chc Healthcare's conference presentation, Dec 25, 2017
Slide 1: 2017 2nd Institutional Investor Conference
2017 2nd Institutional Investor Conference 4164 TT
Slide 2: Disclaimer
Disclaimer • The information contained in this confidential document ("Presentation") has been prepared by CHC Healthcare Group (the "Company"). It has not been fully verified and is subject to material updating, revision and further amendment. • While the information contained herein has been prepa
Slide 3: Company Overview, Operational Results, Future Guidance, Q&A
Company Operational Future Q&A Overview Results Guidance 3
Slide 4: Company Overview
Company Operational Future Q&A Overview Results Guidance 4
Slide 5: Company Introduction
Company Introduction • Name ： CHC Healthcare Group (4164 TT) • Date of Establish ： 2009/11/27 (First subsidiary, Chiu Ho Instruments & Reagent, was founded in 1977) • President ： Mr. Pei-Lin, Lee • Headquarters ： Taipei • Branches ： Taichung, Kaohsiung, Beijing, Guangzhou & Jakarta • Major Business
Slide 6: Company Milestones
Company Milestones 1977 Founded Chiu Ho Instruments & Reagent Co., Ltd Holding “2017 International Elderly Care Industry Leaders 2017 Forum” IBA first official revenue sharing contract signed in Taiwan 1985 Introduced radiotherapy equipment IBA first official direct selling contract signed in Taiwan
Slide 7: Management Team
Management Team China Taiwan Goung-Yu, Chen General Manager Ming-Lun, Lee Vice President Great China Sales Business Group II/ (Sales Director, GE Healthcare) Strategic Development Business Group Yee-Min, Jen Chief Executive Officer Yi-Chun, Chen Vice President Oncology Business Group Finance Account
Slide 8: Solid Partnership with Top Global Brands
Solid Partnership with Top Global Brands Radiation Oncology Medical Imaging Ophthalmology & Neuroscience 8
Slide 9: Full Service Solution Provider "TurnKey Solutions"
Full Service Solution Provider “TurnKey Solutions” Manufacturer Technical & Service Product Strength Strength Top Global Brands Service Team Certified CHC Healthcare Group • Radiation Oncology by Manufacturers • Neuroscience Revenue Technical ．Site Planning Sharing Direct Selling • Ophthalmology Par
Slide 10: Product Mix
Product Mix Service revenue 9% Sales Revenue revenue Sharing 49% 42% 2016 Annual Value-Added Business Model 10
Slide 11: Operational Results
Company Operational Future Q&A Overview Results Guidance 11
Slide 12: Big Success in IBA Proton Therapy
Big Success in IBA Proton Therapy Business Model for Both Direct Selling & Revenue Sharing 12
Slide 13: Precision Medicine
———“‘“‘CS SC Precision Medicine 120 + 1 Pee Y Electrons (21 MeV) | Carbon (270 MeV/u) | A Photons Protons | 8 8 ro) 8 13 KRESS CHC HEALTHCARE GROUP
Slide 14: IBA Proton Therapy Unrivaled Experience
IBA Proton Therapy Unrivaled Experience 30+ 40+ 50,000+ 60%+ YEARS OF EXPERIENCE PARTNER INSTITUTIONS PATIENTS TREATED MARKET SHARE 14
Slide 15: Proton Design Flexibility
Proton Design Flexibility ProteusPLUS ProteusONE 1,800m2 300 m2 15
Slide 16: Revenue Sharing Partnership
Revenue Sharing Partnership Taiwan China Indonesia 16
Slide 17: Monthly Sales
Monthly Sales 2,000,000 1,800,000 1,600,000 1,400,000 1,200,000 1,000,000 2016 800,000 2017 600,000 400,000 200,000 0 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec YTD 2016 2017 YoY 2016 2017 YoY Jan 120,683 110,226 -8.66% Jul 118,302 145,050 22.61% Feb 93,992 163,062 73.48% Aug 137,056 155,094 13
Slide 18: Q1-Q3 Results
Q1-Q3 Results 1,600,000 2016 2017 Q1-Q3 Q1-Q3 Operating Revenue 1,396,967 1,498,994 1,200,000 Gross Profit 361,532 491,060 Gross Margin(%) 26% 33% 800,000 Net Operating Income 136,252 232,816 2016 Q1-Q3 OP Margin (%) 10% 16% 2017 Q1-Q3 Net Profit 36,229 114,779 400,000 Net Margin (%) 3% 8% Profit (p
Slide 19: EY Entrepreneur of the Year 2017 in Taiwan
EY Entrepreneur of the Year 2017 in Taiwan Advancing Pioneer Entrepreneur of the Year Pei-Lin, Lee President of CHC Healthcare Group “Full Service Solution Provider” ･Lower cost of hospitals by providing medical management service ･ Improve medical environment ･ Help disadvantaged through core busin
Slide 20: Future Guidance
Company Operational Future Q&A Overview Results Guidance 20
Slide 21: Entering Long-Term Care Market
Entering Long-Term Care Market 21
Slide 22: High-End Brand
High-End Brand | + i I
Slide 23: Introduce New Product - Elekta MR-Linac
Introduce New Product - Elekta MR-Linac 23
Slide 24: Elekta - Unity
Elekta - Unity 24
Slide 25: Elekta - Unity
Elekta - Unity Soft Tissue Imaging with Diagnostic Quality + HD Dynamic Radiosurgery 25
Slide 26: Elekta - Unity
Elekta - Unity MR-Linac Diagnostic MRI With state-of-the-art, 160-leaf MLC 1.5T HIGH-FIELD MR IMAGING For crystal clear target visualization SLIP RING TECHNOLOGY Up to 6x faster gantry rotation for continuous treatment at any angle INTELLIGENT SOFTWARE Integrated workflow for unprecedented personali
Slide 27: Product Diversification
Products and Geography Expansion Long-Term Care Business Product Diversification New Cancer Center Consulting & Management Products (Taiwan、China、Southeast Asia) Neuroscience, Medical Imaging, Ophthalmology Equipment IBA Proton Therapy Existing Novadaq Fluorescence Imaging Technology (Greater China)
Slide 28: Company Overview, Operational Results, Future Guidance, Q&A
Company Operational Future Overview Results Guidance Q&A 28
Slide 29: Thank you
Thank you 29
CHC Healthcare Group — 2017 2nd Institutional Investor Conference on 6ix